Why Amylyx is pulling ALS drug Relyvrio from US market after study
Release time：2024-05-21 16:31:39 Source：Stellar Series news portal
WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn’t help patients with the deadly neurological condition.
Amylyx Pharmaceuticals announced it will voluntarily halt sales and marketing of the drug in the U.S. and Canada, where new patients will no longer be able to get a prescription.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS,” company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
The Food and Drug Administration approved the much-debated drug, Relyvrio, in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS.
- Previous：‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
- Next：Who is Jacob Zuma, the former South African president disqualified from next week's election?
Related articles
- Children are evacuated from school 'during an exam' after threat made via email
- Hulunbuir takes various measures to boost local tourism market
- Xi Story: A Farmland Visitor and the Vision for China's Food Security
- Newborn golden snub
- Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
- Village benefits from ecological improvement of Erhai Lake in Yunnan
- Rainbow seen at Hukou Waterfall scenic spot in China's Shaanxi
- Moss pink flowers in full bloom in Heibei
- Brazil replaces injured goalkeeper Ederson in Copa America squad
- Scenery of Sanhuan pastureland in Dalian, NE China's Liaoning
- Liverpool confirms Arne Slot as Jurgen Klopp's replacement
- Autumn scenery of park along Changhe River in Hebei
- Azalea flowers enter blooming season in Guizhou, SW China
- Number of migrant birds increases in Ulungur Lake National Wetland Park
- Bella Hadid goes braless in a thigh
- Acrobatic rendition of The Swan Lake staged in Fuzhou
- China strives to build stronger rural tourism
- Canada's tourism spending sharply down in 2020
- Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
- Wild animals frequently spotted along a river valley in Tibet, indicating improving biodiversity
Random recommendation
- Copyright © 2024 Powered by Why Amylyx is pulling ALS drug Relyvrio from US market after study ,Stellar Series news portal sitemap